2-Chloro-N-((5-(5-(trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-3-yl)methyl)benzenesulfonamide

Catalog No. :
ACAWBH135
CAS No. :
1311279-94-3
Molecular Formula :
C15H10ClF3N4O3S
Molecular Weight :
418.78

IUPAC Name:2-chloro-N-((5-(5-(trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-3-yl)methyl)benzenesulfonamide

2-Chloro-N-((5-(5-(trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-3-yl)methyl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-((5-(5-(trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-3-yl)methyl)benzenesulfonamide
IUPAC Name2-chloro-N-((5-(5-(trifluoromethyl)pyridin-2-yl)-1,2,4-oxadiazol-3-yl)methyl)benzenesulfonamide
MDL No.MFCD19981145
Molecular FormulaC15H10ClF3N4O3S
Molecular Weight418.78
SMILESO=S(C1=CC=CC=C1Cl)(NCC2=NOC(C3=NC=C(C(F)(F)F)C=C3)=N2)=O
InChI KeySSMYYTFUDHMNOD-UHFFFAOYSA-N
Synonym2-Chloro-N-[5'-(5''-(trifluoromethyl)pyridin-2''-yl)--[1',2',4']oxadiazol-3'-ylmethyl]benzenes;2-Chloro-N-[5-(5-(trifluoromethyl)pyridin-2-yl)--[1,2,4]oxadiazol-3-ylmethyl]benzenesulphonamide;Benzenesulfonamide, 2-chloro-N-[[5-[5-(trifluoromethyl)-2-pyridinyl]-1,2,4-oxadiazol-3-yl]methyl]-
CAS No.1311279-94-3

Synthetic Route by SureRoute

1. ACAWBH135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAWBH135 route product structure diagram
    ACAWBH1351311279-94-3
Inquiry

2. ACAWBH135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAWBH135 route product structure diagram
    ACAWBH1351311279-94-3
Inquiry

Comments (0)